Wanfu Biotech announced that on July 29, 2026, the company first repurchased 65,200 shares through centralized bidding transactions, accounting for 0.0028% of the total share capital. The highest transaction price was 16.75 yuan/share, the lowest transaction price was 16.65 yuan/share, and the total transaction amount was 1.089 million yuan. Previously, the board of directors of the company had reviewed and approved the repurchase plan. The total capital was not less than 30 million yuan and no more than 60 million yuan. The repurchase price was no more than 27.06 yuan/share, and the implementation period was 3 months.

Wanfu Biotech announced that on July 29, 2026, the company first repurchased 65,200 shares through centralized bidding transactions, accounting for 0.0028% of the total share capital. The highest transaction price was 16.75 yuan/share, the lowest transaction price was 16.65 yuan/share, and the total transaction amount was 1.089 million yuan. Previously, the board of directors of the company had reviewed and approved the repurchase plan. The total capital was not less than 30 million yuan and no more than 60 million yuan. The repurchase price was no more than 27.06 yuan/share, and the implementation period was 3 months.